EUVIMEDEUVIMED entdecken
Crossref

P-glycoprotein and its role in drug-drug interactions

Andrew Finch, Peter Pillans

Australian Prescriber · 01.08.2014 · 37 (4) · 137-139

DOI: 10.18773/austprescr.2014.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian Prescriber, erschienen am 01.08.2014. Verfasst von Andrew Finch und 1 weiteren Autor:innen. Die Arbeit wurde bisher 193-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efflux transporters such as P-glycoprotein play an important role in drug transport in many organs.In the gut, P-glycoprotein pumps drugs back into the lumen, decreasing their absorption.Drugs which induce P-glycoprotein, such as rifampicin, can reduce the bioavailability of some other drugs.Inhibitors of P-glycoprotein, such as verapamil, increase the bioavailability of susceptible drugs.Many, but not all, of the drugs which are transported by P-glycoprotein are also metabolised by cytochrome P450 3A4.Important substrates of P-glycoprotein include calcium channel blockers, cyclosporin, dabigatran etexilate, digoxin, erythromycin, loperamide, protease inhibitors and tacrolimus.Predicting clinically important interactions is difficult because of interindividual differences in drug transport. Drug absorptionThe epithelial cell lining of the small intestine is not just a site for drug absorption, but also an important barrier to the absorption of xenobiotics.P-glycoprotein is found in the apical (luminal) membrane of the entire intestine from duodenum to rectum, with a high expression in the enterocytes of the small intestine.It reduces the oral availability of drugs that are its substrates.3,4 Like the enzymes involved in drug metabolism, substrates of P-glycoprotein can potentially act as inhibitors or inducers of its function.Inhibition of P-glycoprotein can result in increased bioavailability of the susceptible drug.Induction of P-glycoprotein reduces the bioavailability. Drug distributionOnce a drug has reached the systemic circulation, P-glycoprotein further limits penetration into a number of sensitive tissues.P-glycoprotein is also important for the blood-brain barrier as a defence against the penetration of toxins and drugs into the central nervous system.3 Drug elimination P-glycoprotein has a modest role in drug elimination.It is expressed in the luminal membrane of proximal tubule cells in the kidneys.P-glycoprotein pumps drugs into the urine. Drug interactionsP-glycoprotein is an important mediator of drug-drug interactions.3 The pharmacokinetics of a drug may

Zitieren

APA

Finch, A., & Pillans, P. (2014). P-glycoprotein and its role in drug-drug interactions. Australian Prescriber, 37(4), 137-139. https://doi.org/10.18773/austprescr.2014.050

Vancouver

Finch A, Pillans P. P-glycoprotein and its role in drug-drug interactions. Australian Prescriber. 2014;37(4):137-139. doi:10.18773/austprescr.2014.050

BibTeX
@article{Finch2014,
  author = {Finch, Andrew and Pillans, Peter},
  title = {P-glycoprotein and its role in drug-drug interactions},
  journal = {Australian Prescriber},
  year = {2014},
  volume = {37},
  number = {4},
  pages = {137--139},
  doi = {10.18773/austprescr.2014.050}
}
Kostenlos starten →